Cornerstone Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $652K | Hold |
|
|||||
|
2025
Q1 | $603K | Sell |
|
|||||
|
2024
Q4 | $696K | Hold |
|
|||||
|
2024
Q3 | $650K | Hold |
|
|||||
|
2024
Q2 | $547K | Hold |
|
|||||
|
2024
Q1 | $475K | Sell |
|
|||||
|
2023
Q4 | $497K | Sell |
|
|||||
|
2023
Q3 | $450K | Sell |
|
|||||
|
2023
Q2 | $795K | Sell |
|
|||||
|
2023
Q1 | $994K | Sell |
|
|||||
|
2022
Q4 | $913K | Sell |
|
|||||
|
2022
Q3 | $1.33M | Hold |
|
|||||
|
2022
Q2 | $1.38M | Hold |
|
|||||
|
2022
Q1 | $1.74M | Buy |
|
|||||
|
2021
Q4 | $2.18M | Sell |
|
|||||
|
2021
Q3 | $2.06M | Hold |
|
|||||
|
2021
Q2 | $1.94M | Hold |
|
|||||
|
2021
Q1 | $2.25M | Sell |
|
|||||
|
2020
Q4 | $2.44M | Buy |
|
|||||
|
2020
Q3 | $897K | Buy |
|
|||||
|
2020
Q2 | $1.04M | Sell |
|
|||||
|
2020
Q1 | $744K | Sell |
|
|||||
|
2019
Q4 | $1.14M | Sell |
|
|||||
|
2019
Q3 | $1.09M | Sell |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $2.43M | Sell |
|
|||||
|
2018
Q4 | $8.67M | Buy |
|
|||||
|
2018
Q3 | $17.3M | Sell |
|
|||||
|
2018
Q2 | $14.5M | Sell |
|
|||||
|
2018
Q1 | $12.4M | Sell |
|
|||||
|
2017
Q4 | $10.4M | Buy |
|
|||||
|
2017
Q3 | $9.72M | Buy |
|
|||||
|
2017
Q2 | $8.21M | Buy |
|
|||||
|
2017
Q1 | $7.04M | Buy |
|
|||||
|
2016
Q4 | $5.99M | Buy |
|
|||||
|
2016
Q3 | $5.54M | Sell |
|
|||||
|
2016
Q2 | $6.9M | Sell |
|
|||||
|
2016
Q1 | $6.59M | Sell |
|
|||||
|
2015
Q4 | $6.78M | Sell |
|
|||||
|
2015
Q3 | $5.41M | Buy |
|
|||||
|
2015
Q2 | $5.96M | Buy |
|
|||||
|
2015
Q1 | $2.01M | Buy |
|
|||||
|
2014
Q4 | $1.38M | Buy |
|
|||||
|
2014
Q3 | $1M | Buy |
|
|||||
|
2014
Q2 | $1.2M | Sell |
|
|||||
|
2014
Q1 | $1.41M | Sell |
|
|||||
|
2013
Q4 | $1.18M | Hold |
|
|||||
|
2013
Q3 | $968K | Sell |
|
|||||
|
2013
Q2 | $958K | Buy |
|